New hope for tough lymphoma: experimental drug combo targets relapsed cases
NCT ID NCT05950165
First seen Mar 31, 2026 · Last updated Jun 17, 2026 · Updated 13 times
Summary
This study tests a new drug called CHO-H01, alone or with another drug (lenalidomide), in people with a type of blood cancer called non-Hodgkin's lymphoma that has returned or not responded to prior treatments. The goal is to find a safe dose and see if the combination can shrink tumors. About 37 adults will take part in this early-stage trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital - Hemato-Oncology
RECRUITINGKaohsiung City, 833, Taiwan
-
Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital - Hematology and Oncology - Hematology and Oncology
TERMINATEDTaoyuan, Taoyuan, 33305, Taiwan
-
Chi-Mei Medical Center
RECRUITINGTainan, Taiwan, 71004, Taiwan
-
China Medical University Hospital - Hematology/Oncology - Taichung
RECRUITINGTaichung, 404, Taiwan
-
National Cheng Kung University Hospital - Internal Medicine
TERMINATEDTainan, 70403, Taiwan
-
National Taiwan University Hospital - Hematology And Oncology
RECRUITINGTaipei, 100, Taiwan
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, Taiwan, 632, Taiwan
-
Taipei Medical University - Shuang Ho Hospital - Oncology
RECRUITINGNew Taipei City, Taipei Special Municipality, 23561, Taiwan
-
Tri-Service General Hospital - Neihu Branch - Hematology
TERMINATEDTaipei, Taipei, 11490, Taiwan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.